India supplies 40% of US generic drugs despite Trump's push

India supplies around 40% of US generic medicines, highlighting America's reliance on Indian drugmakers, a report says. A Hyderabad plant produces nearly one billion oral doses monthly, mostly for the US. Trump's proposed tariffs aim to boost domestic production, but experts warn manufacturing medicines in America could cost four times more than in India.